Your session is about to expire
← Back to Search
Behavioral Intervention
Circadian Intervention for Obesity (TOCS Trial)
N/A
Recruiting
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age: 18-45 years old; equal numbers of men and women
Be between 18 and 65 years old
Must not have
Evidence of significant organ dysfunction or disease (e.g., diagnosed diabetes, cardiovascular disease, or kidney disease)
Clinically diagnosed sleep disorder or major psychiatric illness
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to week 8 of the ~8 week experimental segment
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare how two interventions help people with overweight/obesity and short sleep duration lose weight. One intervention focuses on reducing nighttime light and snack food, the other on health info.
Who is the study for?
This trial is for adults aged 18-45 with a BMI of 25.0-34.9 who sleep less than 6.5 hours nightly and are not currently in weight loss programs or experiencing menopause. It's not for those with significant organ diseases, diagnosed sleep disorders, psychiatric illnesses, heavy alcohol use, recent shift work history, or using drugs affecting sleep/glucose metabolism.
What is being tested?
The study tests a circadian intervention aimed at improving cardiometabolic health by reducing nighttime light exposure and after-dinner snacks versus a control group receiving basic health advice on physical activity and nutrition.
What are the potential side effects?
Potential side effects aren't specified but may include changes in sleeping patterns or appetite due to the lifestyle adjustments required by the circadian intervention compared to usual habits.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 45 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a significant health condition like diabetes, heart, or kidney disease.
Select...
I have been diagnosed with a sleep disorder or major psychiatric illness.
Select...
I am experiencing menopause or am post-menopausal.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to week 8 of the ~8 week experimental segment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to week 8 of the ~8 week experimental segment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Insulin sensitivity change from baseline
Secondary study objectives
Average (per week) daytime alertness change from baseline
Average (per week) nightly total sleep time change from baseline
Average (per week) self-reported sleep duration change from baseline
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Circadian-based intervention focused on timing of light exposure and food intake.
Group II: Control GroupActive Control1 Intervention
Provided with general health information on diet and physical activity.
Find a Location
Who is running the clinical trial?
University of UtahLead Sponsor
1,147 Previous Clinical Trials
1,699,601 Total Patients Enrolled
1 Trials studying Sleep Hygiene
70 Patients Enrolled for Sleep Hygiene